A randomized, blinded, multicenter, parallel study comparing the efficacy and safety of pulmicort [budesonide] respules at 0.5mg QD, 1.0mg QD, 1.0mg bid, 2.0mg bid and pulmicort turbuhaler at 4.00mcg bid on adolescents (12 yrs of age and older) with adults with moderate to severe asthma

Trial Profile

A randomized, blinded, multicenter, parallel study comparing the efficacy and safety of pulmicort [budesonide] respules at 0.5mg QD, 1.0mg QD, 1.0mg bid, 2.0mg bid and pulmicort turbuhaler at 4.00mcg bid on adolescents (12 yrs of age and older) with adults with moderate to severe asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Apr 2008

At a glance

  • Drugs Budesonide (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 11 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top